EMEA-002861-PIP02-20-M03
Table of contents
Key facts
| Invented name |
Comirnaty
|
| Active substance |
Tozinameran
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0547/2021
|
| PIP number |
EMEA-002861-PIP02-20-M03
|
| Pharmaceutical form(s) |
Concentrate for solution for injection
|
| Condition(s) / indication(s) |
Prevention of Coronavirus disease 2019 (COVID-19)
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
BioNTech Manufacturing GmbH
Email: pediatric@biontech.de |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|